logo
This 60-calorie snack may help turn back time — especially for Gen X and millennial women

This 60-calorie snack may help turn back time — especially for Gen X and millennial women

New York Post03-05-2025

Forget pricey creams and supplements, a powerful anti-aging tool is probably sitting in a jar in your pantry.
The simple 60-calorie snack, rich in antioxidants, healthy fats, fiber and minerals, has been a health and beauty staple since the time of the ancient Greeks.
And for Gen X and millennial women, there's an extra perk: it could help alleviate symptoms linked to the menopause transition.
Advertisement
3 The bite-sized snack can be enjoyed on its own or tossed into other dishes to boost flavor.
nenetus – stock.adobe.com
Tiny but mighty
They might be small, but olives are nutritional powerhouses.
Grown on trees native to the Mediterranean, Asia, and Africa, the color of these tiny stone fruits changes depending on when they are picked. Green olives are usually harvested before they're fully ripe, while black olives are left to fully mature on the tree, according to BBC Good Food.
That extended ripening time is what gives black olives the edge in the nutrient department.
Advertisement
The anti-aging power of black olives
Think black olives are just a tasty topping? Nope. These bite-sized flavor bombs are loaded with age-fighting nutrients that do more than just spice up your charcuterie board.
Loaded with antioxidants like polyphenols, black olives help neutralize harmful free radicals in the body. When these unstable molecules run rampant, they cause oxidative stress, a process that damages cells, accelerates aging, and increases the risk of serious health problems like heart disease and stroke.
3 Black olives are left to ripen longer on the tree before being harvested.
Pixel-Shot – stock.adobe.com
Advertisement
Black olives also deliver a hefty dose of vitamin E, which helps support cell function and protects the skin from sun damage — a major contributor to premature aging.
Your skin gets an extra boost from oleuropein, a compound found in black olives that can stimulate cell regeneration and promote collagen production. This helps reduce the appearance of fine lines and wrinkles, giving your skin a youthful glow.
But olives don't just protect your skin from the effects of aging.
Advertisement
Those same polyphenols help combat oxidative stress in the brain — a factor linked to cognitive decline and neurodegenerative diseases.
Black olives also contain oleic acid, a healthy fat that may support memory and brain function. Some studies suggest it could help slow signs of Alzheimer's and keep your thinking sharp.
Olives also lend a hand when it comes to bone health. Animal and test-tube studies have shown that some of the plant compounds in the tiny fruits may help prevent bone loss — a big deal as we age and face a greater risk of osteoporosis, according to Healthline.
That's just the start. Research suggests that black olives may also support heart and eye health, lower high blood pressure, reduce bad cholesterol, improve gut health and even help protect against certain cancers.
A bite of menopause relief
From hot flashes to mood swings and night sweats, navigating the menopause transition can feel like your body is fighting against you.
3 Black olives may help alleviate perimenopause symptoms triggered by oxidative stress and inflammation.
Monkey Business – stock.adobe.com
During perimenopause — the years-long journey leading up to menopause — the body experiences an uptick in oxidative stress and inflammation, Yaraseth del Castillo Ortega, nutritionist at the Antiaging Medical Institute in Madrid, told Vogue.
Advertisement
That's where black olives come in. Castillo Ortega explained that a diet rich in polyphenols, the plant compound found in black olives, has been shown to help reduce inflammation and oxidative stress, both of which can fuel uncomfortable perimenopause symptoms.
'In our personalized approach to women's health, their value goes far beyond taste—they are a small, therapeutic tool that we use with precision within our package of nutritional strategies focused against inflammation and in favor of metabolism and hormonal health,' she said.
How many olives should you eat?
While olives are a nutritional powerhouse, there's one catch: they're high in salt, according to GoodRx.
Advertisement
That means portion control is essential — especially if you have conditions like high blood pressure or kidney disease that require keeping your sodium intake in check.
Experts recommend sticking to about a quarter cup, or roughly 10 olives, which adds up to around 60 calories. That's the perfect balance to enjoy all the health benefits without overdoing it on the salt.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The Cause of Alzheimer's Might Be Coming From Within Your Mouth
The Cause of Alzheimer's Might Be Coming From Within Your Mouth

Yahoo

time3 hours ago

  • Yahoo

The Cause of Alzheimer's Might Be Coming From Within Your Mouth

In recent years, an increasing number of scientific investigations have backed an alarming hypothesis: Alzheimer's disease may not be merely a condition of an aging brain, but the product of infection. While the exact mechanisms of this infection are something researchers are still trying to isolate, numerous studies suggest the deadly spread of Alzheimer's goes way beyond what we used to think. One such study, published in 2019, suggested what could be one of the most definitive leads yet for a bacterial culprit behind Alzheimer's, and it comes from a somewhat unexpected quarter: gum disease. Watch the video below for a summary of their study: In a paper led by senior author Jan Potempa, a microbiologist from the University of Louisville, researchers reported the discovery of Porphyromonas gingivalis – the pathogen behind chronic periodontitis (aka gum disease) – in the brains of deceased Alzheimer's patients. It wasn't the first time the two factors have been linked, but the researchers went further. In separate experiments with mice, oral infection with the pathogen led to brain colonization by the bacteria, together with increased production of amyloid beta (Aβ), the sticky proteins commonly associated with Alzheimer's. The research team, coordinated by pharma startup Cortexyme, which was co-founded by first author Stephen Dominy, wasn't claiming to have discovered definitive evidence of Alzheimer's causation. But it was clear they thought we had a strong line of investigation here. P. gingivalis' gingipains (red) among neurons in the brain of a patient with Alzheimer's. (Cortexyme) "Infectious agents have been implicated in the development and progression of Alzheimer's disease before, but the evidence of causation hasn't been convincing," Dominy said at the time. "Now, for the first time, we have solid evidence connecting the intracellular, Gram-negative pathogen, P. gingivalis, and Alzheimer's pathogenesis." In addition, the team identified toxic enzymes called gingipains secreted by the bacteria in the brains of Alzheimer's patients, which correlated with two separate markers of the disease: the tau protein, and a protein tag called ubiquitin. But even more compellingly, the team identified these toxic gingipains in the brains of deceased people who were never diagnosed with Alzheimer's. That's important, because while P. gingivalis and the disease have been linked before, it's never been known – to put it simply – whether gum disease causes Alzheimers, or whether dementia leads to poor oral care. The fact that low levels of gingipains were evident even in people who were never diagnosed with Alzheimer's could be a smoking gun – suggesting they might have developed the condition if they had lived longer. "Our identification of gingipain antigens in the brains of individuals with AD and also with AD pathology but no diagnosis of dementia argues that brain infection with P. gingivalis is not a result of poor dental care following the onset of dementia or a consequence of late-stage disease, but is an early event that can explain the pathology found in middle-aged individuals before cognitive decline," the authors explained in their paper. Further, a compound formulated by the company called COR388, showed in experiments with mice that it could reduce bacterial load of an established P. gingivalis brain infection, while also reducing amyloid-beta production and neuroinflammation. We'll have to wait and see what future research will uncover about this link, but the research community is cautiously optimistic. "Drugs targeting the bacteria's toxic proteins have so far only shown benefit in mice, yet with no new dementia treatments in over 15 years it's important that we test as many approaches as possible to tackle diseases like Alzheimer's," chief scientific officer David Reynolds from Alzheimer's Research commented in a statement. The findings were reported in Science Advances. An earlier version of this story was published in January 2019. Common Diabetes Drug Linked to 'Exceptional Longevity' in Women Increased Toxicity Risk Identified For Children With ADHD, Autism Coffee Could Be The Secret to Healthy Aging For Women, Scientists Discover

New FDA-approved Alzheimer's blood test coming to Mayo Clinic
New FDA-approved Alzheimer's blood test coming to Mayo Clinic

Yahoo

time8 hours ago

  • Yahoo

New FDA-approved Alzheimer's blood test coming to Mayo Clinic

The Brief The FDA has approved the marketing of a new blood test by Fujirebio. The biomarker test measures the ratio of tau and amyloid proteins in the blood of a person with symptoms of cognitive decline to confirm the presence of Alzheimer's disease. Mayo Clinic will be one of 37 Alzheimer's clinics across the country to receive the new blood testing equipment starting at the end of June. MINNEAPOLIS (FOX 9) - The U.S. Food and Drug Administration has approved the marketing of a new tool to that can test a person's blood to diagnose Alzheimer's disease. The blood test is a groundbreaking development to confirm the disease in patients who are already experiencing cognitive decline. What we know The diagnostic tool, called Lumipulse, is manufactured by the world-wide medical research and development firm Fujirebio. The procedure, called the G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test, measures the presence of the amyloid and tau proteins in the brain that build the plaques leading to Alzheimer's disease. Fujirebio will now start distributing the diagnostic tests by the end of June to 37 Alzheimer's clinics across the United States including Mayo Clinic in Rochester, Minnesota. "I was very excited to get the news that there was an FDA approved test," said Alicia Algeciras-Schimnich, Ph.D. of Mayo Clinic who's been offering a version of the blood test for the past year in their laboratory. "It's just increasing the access to patients, and now many more laboratories will be able to offer this test." Dr. Algeciras-Schimnich says Mayo hopes will have the capacity to offer 1,000 to 5,000 blood tests a month with this new diagnostic protocol. What patients say Tim Sandry admits he's never had the best memory, but when he approached turning 67, he and his wife Ellen started noticing changes. "I wanted to find out what's going on here," recalled Sandry when he and his wife decided to see a neurologist. The doctor put him through a series of cognitive tests and determined he had what's called mild cognitive impairment which is a noticeable slowing of memory function. It wasn't long after his cognitive tests that a new diagnostic spinal tap was available to detect the presence of Alzheimer's disease. But it was invasive and painful. "In the morning they took the spinal fluid, and then I had to stay very still for the rest of the day. And then they sent me home, and I had an awful headache for the next three days," said Sandry of the hospital procedure. This new test would have saved him the pain and provided reliable results. "Oh, so much difference," said Sandry about the chance to have had a diagnostic blood test. "I mean, this blood test is going to shake things up dramatically I believe." Why you should care The faster a person experiencing cognitive decline can get a positive diagnosis for Alzheimer's the faster they can start taking one of two recently FDA approved drugs to slow the progression of the disease. Those drugs are Leqembi and Kisunla. "It makes it much quicker for those people to start treatment and to start looking at what options there are, whether it's clinical trials or medication," said Jenna Fink of the Alzheimer's Association Minnesota-North Dakota chapter. Sandry has been on a regimen of Leqembi since his own diagnosis and he believes it has dramatically slowed the disease in his own brain. "The sooner you get diagnosed, the quicker you can get on those drugs and the less damage this will do to your brain And the longer you will be able to function, cognitively," he said. Dig deeper The new blood test not only speeds up the diagnosis process, it also offers more accuracy. "The clinical diagnosis of Alzheimer disease is only about 70-75% accurate," said Mayo's Alicia Algeciras-Schimnich of the standard practice of cognitive testing and PET scans of the brain. Adding the blood biomarker test increases the accuracy of an Alzheimer's diagnosis to 90-95%. "So really, it is a significant improvement in the diagnosis for patients, which now can have an earlier answer for their symptoms," said Algeciras-Schmnich.' By the numbers As many as 101,900 Minnesotan over the age of 65 are living with Alzheimer's according to the 2025 facts and figures report from the Alzheimer's Association. That adds up to 10.7% of Minnesota adults over 65. Alzheimer's affects more than just the patients. For every patient, there are caregivers, many of them family members. When those numbers are added up, the Alzheimer's Association estimates there are 166,000 caregivers in Minnesota. Across the nation, 7.2 million Americans are living with the Alzheimer's, and 74% are over the age of 75.

Advocates help raise awareness in Harrison County for Alzheimer's and Brain Awareness Month
Advocates help raise awareness in Harrison County for Alzheimer's and Brain Awareness Month

Yahoo

time13 hours ago

  • Yahoo

Advocates help raise awareness in Harrison County for Alzheimer's and Brain Awareness Month

CLARKSBURG, (WBOY) — June is Alzheimer's and brain awareness month, and here in West Virginia, more than 38,000 people aged 65 and older have been diagnosed with Alzheimer's or some sort of dementia, according to the Alzheimer's Impact Movement. And as the age of people diagnosed is decreasing, general concern is increasing. Advocates of the cause are helping raise awareness of Alzheimer's and brain health by speaking with local city councils. These advocates were granted a proclamation on behalf of the Harrison County Commission in its meeting on Wednesday, the Clarksburg City Council on Thursday, and will receive one from the Bridgeport City Council on Friday. 12 News spoke with Bill O'Field, Mission Chairman of the North Central Walk to End Alzheimer's, who spoke with doctors from the WVU Rockefeller Neuroscience Institute on what some of the key signs of dementia and Alzheimer's may look like. Harrison County commissioners split on future of Sunset Ellis property 'It's normal in the aging process to maybe forget a name or forget where you put your car keys, but then you find them. And maybe later in the day, the seniors say, 'but then I remember that name when I get home. The doctor said that's good.' That's just the normal aging process taking place. But it's when you can't cook for yourself, you don't know how to do your laundry, those are the true signs of Alzheimer's,' said O'Field. O'Field also mentioned to be wary of weight loss and depression, and to maintain a healthy diet and exercise, as a healthy body can help result in a healthy mind. The Harrison County Senior Center offers an Alzheimer's support group in its boardroom at 10 a.m. on the second Thursday of each month. You can call 304-623-6795 for more information. The North Central Walk to End Alzheimer's will also be held on Oct. 5 this year at the Meadowbrook Mall with registration beginning at 1 p.m. and the ceremony beginning at 2 p.m. For more information about Alzheimer's and local resources, you can call 800-272-3900 or click here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store